Ilan Daskal - Sep 2, 2022 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role
EVP, Chief Financial Officer
Signature
/s/ Timothy S. Ernst, attorney-in-fact
Stock symbol
BIO
Transactions as of
Sep 2, 2022
Transactions value $
-$128,668
Form type
4
Date filed
9/7/2022, 02:04 PM
Previous filing
Sep 6, 2022
Next filing
Apr 11, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +541 +79.44% $0.00 1.22K Sep 2, 2022 Direct F1
transaction BIO Bio-Rad A Common Stock Tax liability -$129K -269 -22.01% $478.32 953 Sep 2, 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO Restricted Stock Units Options Exercise $0 -541 -33.29% $0.00 1.08K Sep 2, 2022 Bio-Rad A Common Stock 541 $0.00 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Class A common stock acquired on the vesting of restricted stock units.
F2 Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F3 On September 2, 2020, the reporting person was granted 2,166 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.